Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies

ISSN： 1746-0794

Source： Future Virology, Vol.5, Iss.2, 2010-03, pp. : 141-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies for the Immunotherapy of Solid Tumours

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-01 ,pp. : 1385-1398

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Identification of Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies and Improvement of Their Potency

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibody-based Genetic Immunotherapy

Current Gene Therapy, Vol. 4, Iss. 3, 2004-09 ,pp. : 347-356

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal antibodies based on hybridoma technology

By Yagami Hisanori Kato Hiroshi Tsumoto Kanta Tomita Masahiro

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 249-263

Future Science

Access to resources Recommend Favorite

100% Human Monoclonal Antibodies in Oncology: Hype or Breakthrough?

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1643-1648

Bentham Science Publishers

Access to resources Recommend Favorite